JUPITER "moderate CKD" subgroup is not truly "moderate" chronic kidney disease
- PMID: 20670769
- DOI: 10.1016/j.jacc.2010.04.025
JUPITER "moderate CKD" subgroup is not truly "moderate" chronic kidney disease
Comment on
-
Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial.J Am Coll Cardiol. 2010 Mar 23;55(12):1266-1273. doi: 10.1016/j.jacc.2010.01.020. Epub 2010 Mar 4. J Am Coll Cardiol. 2010. PMID: 20206456 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical